BiondVax Pharmaceuticals Ltd (BVXV): BVXV buy 5.990 http://www.biondvax....

stocktrademan · 2018-01-03T16:10:24.6030000Z

BVXV buy 5.990 i.imgur.com/I38pZJ7.png http://www.biondvax.com/ BiondVax Pharmaceuticals, a publicly-traded company in Israel (TASE: BVXV) and the United States (NASDAQ: BVXV), is dedicated to the development of a novel Universal Influenza Vaccine. BiondVax’s Universal Flu Vaccine is based on research carried out over two decades by Weizmann Institute of Science Professor Ruth Arnon, who heads the company’s Scientific Advisory Board. Professor Arnon is well-known for her part in the development of Copaxone®, a blockbuster drug for the treatment of multiple sclerosis. i.imgur.com/lHvpWa4.jpg BiondVax Universal Flu Vaccine Patent Granted in India http://www.biondvax.com/2018/01/biondvax-universal-flu-vaccine-patent-granted-in-india/ Corporate Presentation http://www.biondvax.com/wp-content/uploads/2017/11/BiondVax-Corporate-Presentation-Q4-2017-Final2.pdf Professor Ruth Arnon interview about BiondVax’s Universal Flu Vaccine [yt]fE4uk3FMSQM[/yt] [yt]9AEMKudv5p0[/yt] http://stockcharts.com/c-sc/sc?s=BVXV&p=D&yr=1&mn=0&dy=0&i=p63159298935&r=1511630828754 http://stockcharts.com/c-sc/sc?s=BVXV&p=W&yr=5&mn=0&dy=0&i=p92231134624&r=1511630871132 http://stockcharts.com/c-sc/sc?s=BVXV&p=D&yr=1&mn=0&dy=0&i=p01898489831&r=1511536918052 http://stockcharts.com/c-sc/sc?s=BVXV&p=W&yr=5&mn=0&dy=0&i=p44780267364&r=1511536953415 http://stockcharts.com/c-sc/sc?s=BVXV&p=D&b=5&g=0&i=p13568110624&r=1479825859695 http://stockcharts.com/c-sc/sc?s=BVXV&p=W&b=5&g=0&i=p13568110624&r=1479825859695 http://stockcharts.com/c-sc/sc?chart=BVXV,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20][iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!lf14][j20444984,y]&r=3555b http://stockcharts.com/c-sc/sc?chart=BVXV,uu[e,a]whclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20][iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!lf14][j20444984,y]&r=3555b normal chart http://www.stockscores.com/chart.asp?TickerSymbol=BVXV&TimeRange=365&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=None&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2=50&Indicator1=None&Indicator2=RSI&Indicator3=MACD&Indicator4=SStoch&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen http://www.stockscores.com/chart.asp?TickerSymbol=BVXV&TimeRange=1825&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=None&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2=50&Indicator1=None&Indicator2=RSI&Indicator3=MACD&Indicator4=SStoch&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen log chart http://www.stockscores.com/chart.asp?TickerSymbol=BVXV&TimeRange=365&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=1&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2=50&Indicator1=None&Indicator2=RSI&Indicator3=MACD&Indicator4=SStoch&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen http://www.stockscores.com/chart.asp?TickerSymbol=BVXV&TimeRange=1825&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=1&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2=50&Indicator1=None&Indicator2=RSI&Indicator3=MACD&Indicator4=SStoch&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

BiondVax Pharmaceuticals Ltd (BVXV)

Reply Private New

Keep Last Read

Next 10 Prev Next

stocktrademan

Send PM Follow Ignore

Followers	507
Posts	10138
Boards Moderated	0
Alias Born	04/28/2014

stocktrademan

Re: None

Wednesday, 01/03/2018 11:10:24 AM

Wednesday, January 03, 2018 11:10:24 AM

BVXV buy 5.990

http://www.biondvax.com/

BiondVax Pharmaceuticals, a publicly-traded company in Israel (TASE: BVXV) and the United States (NASDAQ: BVXV), is dedicated to the development of a novel Universal Influenza Vaccine. BiondVax’s Universal Flu Vaccine is based on research carried out over two decades by Weizmann Institute of Science Professor Ruth Arnon, who heads the company’s Scientific Advisory Board. Professor Arnon is well-known for her part in the development of Copaxone®, a blockbuster drug for the treatment of multiple sclerosis.